The Prevalence of Psychosocial Distress and the Role of Discrimination in Latinx/Hispanic Women with Cardiovascular Disease and Its Impact on Quality of Life


About this study

The objectives of this study are to measure psychosocial cardiac distress* in Latinx/Latino/Hispanic (L/H) women with a history of an acute coronary syndrome (ACS), as well as those with traditional cardiovascular risk factors, but no ACS (diabetes, hypercholesterolemia, obesity, and hypertension), to examine the effects a composite measure for psychosocial cardiac distress has on health-related quality of life (QoL) on women with ACS and those with cardiovascular risk factors and to examine the impact acculturation, acculturative stress, perceived discrimination, and familism can have on the association between cardiac distress and QoL on L/H women with ACS and cardiovascular risk factors. 

*Cardiac distress is defined as a multidimensional construct that includes several areas of distress (anxiety, depression, stress, anger, social support, traumatic distress, and vital exhaustion).  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Acute Coronary Syndrome (ACS) Group includes women with a history (7 weeks or more) of an ACS and those with a recent (6 weeks or less) ACS.
    • ACS is defined as non-ST-elevation myocardial infarction (NSTEMI), ST-elevation MI (STEMI), and unstable angina requiring hospitalization. 
  • CVD-RF group includes women with a history of diabetes, hypertension, hyperlipidemia, and obesity but no ACS.

Exclusion Criteria:

  • Males.
  • Non-Hispanics/Latinx.
  • Active substance abuse.
  • Active mania and/or psychosis.
  • Diagnosis of neurocognitive disorder.
  • Stroke with residual cognitive symptoms.
  • Inability to read/write in English and/or Spanish.

Eligibility last updated 12/7/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Laura Suarez Pardo, M.D.

Contact us for the latest status

Contact information:

Laura Suarez Pardo M.D.

(507) 293-9438

More information


Publications are currently not available

Mayo Clinic Footer